skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8852

Reporting of results of interventional studies by the information service of the National Institutes of Health

Original Research

(1897) Views  (474) Full article downloads

Authors: Tatyana Shamliyan

Published Date September 2010 Volume 2010:2 Pages 169 - 176
DOI: http://dx.doi.org/10.2147/CPAA.S12398

Tatyana Shamliyan
Division of Health Policy and Management, University of Minnesota School of Public Health, MN, USA

Abstract: The Food and Drug Administration Amendments Act of 2007 mandated that sponsors of applicable studies must provide results within one year of study completion. We aimed to analyze the factors associated with reporting of results from interventional studies registered on ClinicalTrials.gov. On May 20, 2010, we retrieved 20 available fields from 57,233 closed studies on the website and identified 31,161 interventional studies that were required to post results. We compared the proportion of studies with results versus studies without results by age, gender, and disease status of participants, by interventions, sponsors, phase of clinical trials, and completion dates. The results of studies were reported for 4.7% of applicable studies, 8% of industry-sponsored studies, 7.5% of Phase II and 6.5% of Phase IV clinical trials, 4.9% of drug studies, and 0% of genetic studies. Withdrawn (n = 486) and suspended (n = 414) interventions did not provide results. The percentage of studies with results varied from 0% to 21% among different sponsors. The first studies with results were completed in 1992. The proportion of studies with results increased over time. Completion dates were not available for 7446 studies. The database does not have fields available to facilitate routine analysis of the rate of compliance with federal law for posting results. The analysis of accuracy of the protocols in relation to the results and publications is not possible without time-consuming evaluation of individual postings and individual publications.

Keywords: registries, research standards, access to information, clinical trials, disclosure




 

Other articles by Dr T Shamliyan



Readers of this article also read:

Role of aliskiren in cardio-renal protection and use in hypertensives with multiple risk factors
Age-related disruption of the lamina dura: Evidence in the mandibular horizontal incompletely impacted third molar
Refinement of rigid-body protein–protein docking using backbone and side-chain minimization with a coarse-grained model
Functional mobility and balance in community-dwelling elderly submitted to multisensory versus strength exercises
Clinicoradiological features of recurrent ischemic stroke: healthcare for poststroke patients
Role of teriparatide in treatment of glucocorticoid-induced osteoporosis
Using systematically observed clinical encounters (SOCEs) to assess medical students’ skills in clinical settings
Erratum - Intracellular heavy metal nanoparticle storage
Long-term follow-up of children thought to have temporary brittle bone disease
Primary care for diabetes mellitus: perspective from older patients
  • Testimonials

    "... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University